Heart failure and hypertrophic cardiomyopathy

I9_HEARTFAIL_AND_HYPERTCARDIOM

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector
diagram bullet

Check conditions

I9_HYPERTROCARDMYOP

1082

diagram downward connector

Check pre-conditions, main-only, mode, registry filters None

0 out of 7 registries used, show all original rules.

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

447

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

432

diagram downward connector
I9_HEARTFAIL_AND_HYPERTCARDIOM

Control definitions

Control conditions not I9_HYPERTROCARDMYOP

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

Key figures

All Female Male
Number of individuals 432 153 279
Unadjusted prevalence (%) 0.11 0.07 0.17
Mean age at first event (years) 60.18 61.67 59.36

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: I9_HEARTFAIL_AND_HYPERTCARDIOM – Heart failure and hypertrophic cardiomyopathy
GWS hits: 6

Survival analyses between endpoints

Plot

before Heart failure and hypertrophic cardiomyopathy
after Heart failure and hypertrophic cardiomyopathy

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Heart failure and hypertrophic cardiomyopathy

Endpoint not on priority list, no data to show.